MedTrace Logo

Effects of a 10-Week Zumba Program in Adults With Hypertension

NCT07735468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-07-30

No results posted yet for this study

Summary

This study aims to evaluate the effects of a 10-week Zumba-based exercise program performed three times per week on blood pressure in adults with hypertension. In addition to the primary outcome of blood pressure, secondary outcomes including medication control, body composition (body weight, body fat percentage, and muscle mass), and psychological outcomes (anxiety, depression, quality of life, emotional well-being, and sleep quality) will be assessed.

Participants will be assigned to either an intervention group, performing the Zumba program, or a control group maintaining their usual lifestyle. Measurements will be conducted at baseline and after the intervention period to determine the effectiveness of the program.

Conditions

Interventions

BEHAVIORAL

Zumba fitness programme

Aquí tienes la descripción para el campo de intervención en ClinicalTrials.gov: A 10-week supervised Zumba Fitness programme consisting of three 50-minute sessions per week on non-consecutive days. Each session was structured in three phases: a warm-up (7 minutes), a main part (36 minutes) based on choreographed Latin dance rhythms (merengue, salsa, reggaeton, cumbia, bachata, among others) following a wave-like intensity pattern, and a cool-down (7 minutes). Sessions were led by a certified Zumba Instructor Network (ZIN) instructor with more than 10 years of experience. Internal load was self-regulated by participants using the Borg CR-10 scale, targeting moderate-to-hard effort levels (RPE 4-6). The control group maintained their usual sedentary lifestyle without participating in any structured exercise programme during the intervention period.

Sponsors & Collaborators

  • Universidad de Extremadura

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-27
Primary Completion
2026-07-06
Completion
2026-07-10

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07735468 on ClinicalTrials.gov